Easton Pharmaceuticals, Inc

Strategic Partnerships

Collaborating and developing alliances with strategic partners around the world.

Read More

Social Responsibility

Easton is dedicated to woman’s health, diagnostic, treatment and preventative care products

Read More

Creating Value

Our goal is to create value for our shareholders through growth and innovation.

Read More

Innovative Products

Easton products focus on the areas of women’s health and emerging cannabis markets.

Read More

What’s New

Jun

Easton Pharmaceuticals Announces It Has Received $400,000 USD In Product Purchase Orders For The Current Quarter From Its Woman’s Diagnostic And Treatment Products Business For The Mexico Market

by Easton Pharmaceuticals

TORONTO, ON–(Marketwired – Jun 26, 2017) – Easton Pharmaceuticals, Inc. (OTC: EAPH), is pleased to announce it has received an

Read More

Jun

Easton Pharmaceuticals Announces It Has Finalized Agreement Terms With Alliance Group For Ownership Stake in Several Businesses On 45 Acres Of Agricultural Land, Which Includes The Cultivation of Medical Marijuana For National Canadian Market

by Easton Pharmaceuticals

Cash Investment Terms Include Guaranteed Revenues Secured With Collateralized Mortgage On Property, Revenues To Commence Within 60 Days TORONTO, ON–(Marketwired

Read More

May

Easton Pharmaceuticals Announces It Has Signed an LOI to Acquire An Interest in a 45 Acre Parcel for the Cultivation of Medical Marijuana in Toronto, Canada; Wholly Owned Subsidiary, iBliss in Birmingham’s UK Vaper Expo

by Easton Pharmaceuticals

TORONTO, ON–(May 24, 2017) – Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) is pleased to announce that it has signed a

Read More

Creating Value For Our Shareholders

Easton Pharmaceuticals has entered into new lucrative business segments within the medical marijuana industry.

Learn More

Easton Pharmaceuticals, Inc

Strategic Partnerships

Social Responsibility

Creating Value

Innovative Products

What’s New

Easton Pharmaceuticals Announces It Has Received $400,000 USD In Product Purchase Orders For The Current Quarter From Its Woman’s Diagnostic And Treatment Products Business For The Mexico Market

Easton Pharmaceuticals Announces It Has Finalized Agreement Terms With Alliance Group For Ownership Stake in Several Businesses On 45 Acres Of Agricultural Land, Which Includes The Cultivation of Medical Marijuana For National Canadian Market

Easton Pharmaceuticals Announces It Has Signed an LOI to Acquire An Interest in a 45 Acre Parcel for the Cultivation of Medical Marijuana in Toronto, Canada; Wholly Owned Subsidiary, iBliss in Birmingham’s UK Vaper Expo

Creating Value For Our Shareholders

Easton Pharmaceuticals, Inc.

Investor Information

Get in Touch

FDA Disclosure